TYW1B

gene
On this page

Also known as RSAFD2MGC87315NCRNA00069LINC00069

Summary

TYW1B (tRNA-yW synthesizing protein 1 homolog B, HGNC:33908) is a protein-coding gene on chromosome 7q11.22-q11.23, encoding S-adenosyl-L-methionine-dependent tRNA 4-demethylwyosine synthase TYW1B (Q6NUM6). Probable component of the wybutosine biosynthesis pathway.

Wybutosine is a hypermodified guanosine found in phenylalanine tRNA. Wybutosine functions to stabilize codon-anticodon interactions during ribosome decoding and therefore supports the maintenance of the reading frame. In yeast, the homolog of this gene is essential for the synthesis of wybutosine. The human genome contains two closely related genes that putatively function in wybutosine synthesis. The open reading frame of this locus is disrupted in some individuals. Thus, this locus appears to be an evolving pseudogene, but may still be functional in some members of the population.

Source: NCBI Gene 441250 — RefSeq curated summary.

At a glance

  • GWAS associations: 8
  • Clinical variants (ClinVar): 85 total
  • MANE Select transcript: NM_001145440

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:33908
Approved symbolTYW1B
NametRNA-yW synthesizing protein 1 homolog B
Location7q11.22-q11.23
Locus typegene with protein product
StatusApproved
AliasesRSAFD2, MGC87315, NCRNA00069, LINC00069
Ensembl geneENSG00000277149
Ensembl biotypeprotein_coding
Entrez441250

Gene structure

Transcript identifiers

Ensembl transcripts: 4 — 4 protein_coding

ENST00000610600, ENST00000612372, ENST00000620995, ENST00000902318

RefSeq mRNA: 3 — MANE Select: NM_001145440 NM_001145440, NM_001412179, NM_001412180

CCDS: CCDS69309

Canonical transcript exons

ENST00000620995 — 14 exons

ExonStartEnd
ENSE000037171127280706672807356
ENSE000037231487269468772694822
ENSE000037242627282685572826985
ENSE000037260637271362172713798
ENSE000037286957282807272828200
ENSE000037298327277741672777533
ENSE000037352237280240072802522
ENSE000037352677257451372575719
ENSE000037396607261667272616839
ENSE000037425897272882272728931
ENSE000037448207262888772628997
ENSE000037470777281538072815481
ENSE000037531567274448472744601
ENSE000037531887281047172810665

Expression profiles

Bgee: expression breadth ubiquitous, 134 present calls, max score 92.09.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 6.4695 / max 110.6306, expressed in 1486 samples.

FANTOM5 promoters (2 alternative TSS)

Promoter IDTPM avgSamples expressed
842805.79251452
842790.6770341

Top tissues by expression

134 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
sural nerveUBERON:001548892.09gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047383.95gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099183.56gold quality
calcaneal tendonUBERON:000370176.72gold quality
bone marrow cellCL:000209274.86gold quality
tonsilUBERON:000237274.36gold quality
granulocyteCL:000009473.54gold quality
skeletal muscle tissueUBERON:000113473.31gold quality
gastrocnemiusUBERON:000138872.72gold quality
ventricular zoneUBERON:000305372.58gold quality
bone marrowUBERON:000237172.50gold quality
muscle of legUBERON:000138371.79gold quality
corpus callosumUBERON:000233671.61gold quality
muscle tissueUBERON:000238571.24gold quality
endocervixUBERON:000045871.22gold quality
uterine cervixUBERON:000000271.16gold quality
ectocervixUBERON:001224970.63gold quality
urinary bladderUBERON:000125570.23gold quality
adrenal tissueUBERON:001830370.21gold quality
right ovaryUBERON:000211870.17gold quality
ovaryUBERON:000099269.52gold quality
liverUBERON:000210768.92gold quality
left ovaryUBERON:000211968.78gold quality
leukocyteCL:000073868.54gold quality
placentaUBERON:000198768.37gold quality
mucosa of transverse colonUBERON:000499168.29gold quality
lower esophagus mucosaUBERON:003583468.20gold quality
popliteal arteryUBERON:000225068.00gold quality
tibial arteryUBERON:000761067.99gold quality
vaginaUBERON:000099667.97gold quality

Single-cell (SCXA)

Detected in 2 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes4.09
E-MTAB-4850no6.82

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

39 targeting TYW1B, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-4747-5P100.0067.902681
HSA-MIR-5196-5P100.0067.982761
HSA-MIR-4795-3P100.0074.624024
HSA-MIR-453199.9969.703181
HSA-MIR-186-5P99.9970.833707
HSA-MIR-570-3P99.9672.414910
HSA-MIR-9983-3P99.9471.483631
HSA-MIR-454-3P99.9174.011925
HSA-MIR-130A-3P99.9073.311861
HSA-MIR-130B-3P99.9073.271850
HSA-MIR-301A-3P99.9073.151839
HSA-MIR-301B-3P99.9073.191836
HSA-MIR-366699.9073.241833
HSA-MIR-429599.9073.111838
HSA-MIR-129-5P99.8870.263273
HSA-MIR-369-3P99.8570.522264
HSA-MIR-3680-3P99.7572.513095
HSA-MIR-3059-5P99.7069.932491
HSA-MIR-320299.6667.702737
HSA-MIR-32599.5866.55358
HSA-MIR-6716-5P99.5668.621244
HSA-MIR-29799.4069.581418
HSA-MIR-124499.3368.38832
HSA-MIR-877-3P99.0968.101637
HSA-MIR-6749-3P99.0065.731443
HSA-MIR-6876-3P98.9765.69765
HSA-MIR-455-3P98.9467.68878
HSA-MIR-62698.8966.21762
HSA-MIR-314998.7767.131639
HSA-MIR-49698.6669.80931

Cross-species orthologs

3 orthologs

OrganismSymbolGene ID
danio_reriotyw1ENSDARG00000062987
mus_musculusTyw1ENSMUSG00000056310
rattus_norvegicusTyw1ENSRNOG00000024352

Paralogs (1): TYW1 (ENSG00000198874)

Protein

Protein identifiers

S-adenosyl-L-methionine-dependent tRNA 4-demethylwyosine synthase TYW1BQ6NUM6 (reviewed: Q6NUM6)

Alternative names: Radical S-adenosyl methionine and flavodoxin domain-containing protein 2, tRNA wybutosine-synthesizing protein 1 homolog B

All UniProt accessions (3): Q6NUM6, A0A087WWV6, A0A087X1V1

UniProt curated annotations — full annotation on UniProt →

Function. Probable component of the wybutosine biosynthesis pathway. Wybutosine is a hyper modified guanosine with a tricyclic base found at the 3’-position adjacent to the anticodon of eukaryotic phenylalanine tRNA. Catalyzes the condensation of N-methylguanine with 2 carbon atoms from pyruvate to form the tricyclic 4-demethylwyosine, an intermediate in wybutosine biosynthesis.

Cofactor. Binds 1 [4Fe-4S] cluster. The cluster is coordinated with 3 cysteines and an exchangeable S-adenosyl-L-methionine.

Pathway. tRNA modification; wybutosine-tRNA(Phe) biosynthesis.

Similarity. Belongs to the TYW1 family.

Isoforms (2)

UniProt IDNamesCanonical?
Q6NUM6-11yes
Q6NUM6-22

RefSeq proteins (3): NP_001138912, NP_001399108, NP_001399109 (=MANE)

Domains & families (InterPro)

IDNameType
IPR001094Flavdoxin-likeDomain
IPR007197rSAMDomain
IPR008254Flavodoxin/NO_synthDomain
IPR013785Aldolase_TIMHomologous_superfamily
IPR013917tRNA_wybutosine-synthDomain
IPR029039Flavoprotein-like_sfHomologous_superfamily
IPR034556tRNA_wybutosine-synthaseFamily
IPR058240rSAM_sfHomologous_superfamily

Pfam: PF00258, PF04055, PF08608

Catalyzed reactions (Rhea), 1 shown:

  • N(1)-methylguanosine(37) in tRNA(Phe) + pyruvate + S-adenosyl-L-methionine = 4-demethylwyosine(37) in tRNA(Phe) + 5’-deoxyadenosine + L-methionine + CO2 + H2O (RHEA:36347)

UniProt features (14 total): binding site 5, compositionally biased region 3, domain 2, chain 1, splice variant 1, sequence conflict 1, region of interest 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q6NUM6-F176.400.44

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Ligand- & substrate-binding residues (5): 356; 359; 43–47; 130–162; 352

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 47 (showing top): GOBP_TRNA_METABOLIC_PROCESS, GOBP_CARBOHYDRATE_DERIVATIVE_METABOLIC_PROCESS, GOBP_RNA_MODIFICATION, GOBP_CARBOHYDRATE_DERIVATIVE_BIOSYNTHETIC_PROCESS, chr7q11, GOBP_GLYCOSYL_COMPOUND_BIOSYNTHETIC_PROCESS, GOBP_TRNA_PROCESSING, GOBP_TRNA_MODIFICATION, GOMF_FMN_BINDING, GOMF_CARBON_CARBON_LYASE_ACTIVITY, GOMF_METAL_CLUSTER_BINDING, GOMF_4_IRON_4_SULFUR_CLUSTER_BINDING, GOMF_OXO_ACID_LYASE_ACTIVITY, GOMF_CATALYTIC_ACTIVITY_ACTING_ON_RNA, GOMF_CATALYTIC_ACTIVITY_ACTING_ON_A_TRNA

GO Biological Process (2): wybutosine biosynthetic process (GO:0031591), tRNA processing (GO:0008033)

GO Molecular Function (9): FMN binding (GO:0010181), metal ion binding (GO:0046872), 4 iron, 4 sulfur cluster binding (GO:0051539), tRNA-4-demethylwyosine synthase activity (GO:0102521), nucleotide binding (GO:0000166), catalytic activity (GO:0003824), protein binding (GO:0005515), lyase activity (GO:0016829), iron-sulfur cluster binding (GO:0051536)

GO Cellular Component (1): membrane (GO:0016020)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
tRNA modification1
glycosyl compound biosynthetic process1
RNA processing1
tRNA metabolic process1
ribonucleotide binding1
anion binding1
cation binding1
iron-sulfur cluster binding1
oxo-acid-lyase activity1
catalytic activity, acting on a tRNA1
nucleoside phosphate binding1
heterocyclic compound binding1
molecular_function1
binding1
catalytic activity1
metal cluster binding1
cellular anatomical structure1

Protein interactions and networks

STRING

538 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
TYW1BOSBPL7Q9BZF2571
TYW1BMTARC1Q5VT66519
TYW1BCOBLL1Q53SF7447
TYW1BNBPF9P0DPF3431
TYW1BABCA8O94911419
TYW1BDEFB132Q7Z7B7402
TYW1BDPY19L3Q6ZPD9399
TYW1BFAM110AQ9BQ89395
TYW1BKLF14Q8TD94380
TYW1BDIPK1AQ5T7M9371
TYW1BANGPTL3Q9Y5C1370
TYW1BIQCEQ6IPM2366
TYW1BIL6RP08887365
TYW1BSP6Q3SY56352
TYW1BJMJD1CQ15652350
TYW1BEML5Q05BV3350

IntAct

26 interactions, top by confidence:

ABTypeScore
RANBP6SLC27A2psi-mi:“MI:0914”(association)0.640
TAS2R19TYW1Bpsi-mi:“MI:0915”(physical association)0.560
POMKTMEM120Bpsi-mi:“MI:0914”(association)0.530
PTGER3PIK3R2psi-mi:“MI:0914”(association)0.530
SPACA1GOLIM4psi-mi:“MI:0914”(association)0.530
TEX264PER1psi-mi:“MI:0914”(association)0.530
ARL15SLC25A20psi-mi:“MI:0914”(association)0.530
TCIRG1AP3D1psi-mi:“MI:0914”(association)0.530
HEATR3SLC27A2psi-mi:“MI:0914”(association)0.530
HTATSF1psi-mi:“MI:0915”(physical association)0.400
SLC18A1LIMK2psi-mi:“MI:0914”(association)0.350
EDNRBEXOC5psi-mi:“MI:0914”(association)0.350
CDKAL1CIAO1psi-mi:“MI:0914”(association)0.350
ENTPD4TYW1Bpsi-mi:“MI:0914”(association)0.350
SPACA1ESYT2psi-mi:“MI:0914”(association)0.350
KLRC4RAP1BLpsi-mi:“MI:0914”(association)0.350
HFEPODXLpsi-mi:“MI:0914”(association)0.350
CD3DCLGNpsi-mi:“MI:0914”(association)0.350
KCNE3TMEM131Lpsi-mi:“MI:0914”(association)0.350
TAS2R19TYW1Bpsi-mi:“MI:0915”(physical association)0.000

BioGRID (34): TYW1B (Affinity Capture-MS), TYW1B (Affinity Capture-MS), TYW1B (Affinity Capture-MS), TYW1B (Affinity Capture-MS), TYW1B (Affinity Capture-MS), TYW1B (Affinity Capture-MS), TYW1B (Affinity Capture-MS), TYW1B (Affinity Capture-MS), TYW1B (Affinity Capture-MS), TYW1B (Affinity Capture-MS), TYW1B (Affinity Capture-MS), TYW1B (Affinity Capture-MS), TYW1B (Affinity Capture-MS), TYW1B (Affinity Capture-MS), TYW1B (Affinity Capture-MS)

ESM2 similar proteins: A0A0K3AXH1, A0A125YYR0, A0A7J6K9S4, B5SNZ6, B8PYG1, B9EHT4, C5E2E7, D0Z5N4, F1RD40, F4I2J8, F4IIZ9, F4J6F6, F4KFS5, F5HB62, G5EG86, O04064, O19132, O48767, O48791, O64953, P23915, P26358, P32351, P34335, P49584, Q0WUY1, Q2PAY3, Q5R4R7, Q60JJ0, Q66654, Q6NUM6, Q6X4W1, Q6XL73, Q755A9, Q75QN6, Q80TL4, Q86ME2, Q8BFX3, Q8GX05, Q8SVC0

Diamond homologs: A0A2U1KZS6, A0A2U1LIM9, A0A7T9QPQ1, A2QS05, A2WZT1, A2Y8E0, A5F3I4, C5YJG8, O04397, O04977, O08336, O08394, O19114, O32214, O54705, O62699, P00388, P00389, P00454, P00455, P04175, P10933, P16435, P16603, P19618, P21890, P29477, P35228, P36587, P37039, P37040, P37116, P37201, P41343, P41344, P41346, P47169, P50126, P79290, Q00141

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

85 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance66
Likely benign4
Benign1

Top pathogenic / likely-pathogenic (0)

SpliceAI

3647 predictions. Top by Δscore:

VariantEffectΔscore
7:72575715:TTAAA:Tacceptor_gain1.0000
7:72575716:TAAA:Tacceptor_gain1.0000
7:72575717:AAACT:Aacceptor_loss1.0000
7:72575718:AACTG:Aacceptor_loss1.0000
7:72575719:ACTG:Aacceptor_loss1.0000
7:72575720:C:CCacceptor_gain1.0000
7:72575720:C:CGacceptor_loss1.0000
7:72575721:T:Gacceptor_loss1.0000
7:72616666:TCTTA:Tdonor_loss1.0000
7:72616667:CTTA:Cdonor_loss1.0000
7:72616668:TTACC:Tdonor_loss1.0000
7:72616669:TAC:Tdonor_loss1.0000
7:72616670:ACCT:Adonor_loss1.0000
7:72616671:C:Gdonor_loss1.0000
7:72616671:CCTTT:Cdonor_gain1.0000
7:72628881:GCTTA:Gdonor_loss1.0000
7:72628882:CTTA:Cdonor_loss1.0000
7:72628883:TTAC:Tdonor_loss1.0000
7:72628884:TACCT:Tdonor_loss1.0000
7:72628885:A:ACdonor_gain1.0000
7:72628885:A:Cdonor_loss1.0000
7:72628886:C:CCdonor_gain1.0000
7:72628886:CCTT:Cdonor_gain1.0000
7:72628993:TGTTG:Tacceptor_gain1.0000
7:72628994:GTTG:Gacceptor_gain1.0000
7:72628995:TTG:Tacceptor_gain1.0000
7:72628995:TTGCT:Tacceptor_loss1.0000
7:72628996:TG:Tacceptor_gain1.0000
7:72628997:GC:Gacceptor_loss1.0000
7:72628998:C:Aacceptor_loss1.0000

AlphaMissense

4498 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
7:72575672:G:CF611L0.881
7:72575672:G:TF611L0.881
7:72575674:A:GF611L0.881
7:72575717:A:CF596L0.874
7:72575717:A:TF596L0.874
7:72575719:A:GF596L0.874
7:72713656:G:CF445L0.874
7:72713656:G:TF445L0.874
7:72713658:A:GF445L0.874
7:72575624:G:CF627L0.873
7:72575624:G:TF627L0.873
7:72575626:A:GF627L0.873
7:72713659:G:CS444R0.872
7:72713659:G:TS444R0.872
7:72713661:T:GS444R0.872
7:72713635:A:CF452L0.861
7:72713635:A:TF452L0.861
7:72713637:A:GF452L0.861
7:72575701:A:GW602R0.854
7:72575701:A:TW602R0.854
7:72810510:A:CF131L0.853
7:72810510:A:TF131L0.853
7:72810512:A:GF131L0.853
7:72616759:A:CF566L0.843
7:72616759:A:TF566L0.843
7:72616761:A:GF566L0.843
7:72810477:G:CF142L0.811
7:72810477:G:TF142L0.811
7:72810479:A:GF142L0.811
7:72744492:G:CF358L0.805

dbSNP variants (sampled 300 via entrez): RS1000025959 (7:72753047 C>T), RS1000305732 (7:72754704 C>T), RS1001067332 (7:72759678 T>A), RS1001346729 (7:72761361 T>C,G), RS1001579949 (7:72756093 A>T), RS1003070739 (7:72762672 T>C), RS1003356005 (7:72805709 G>C), RS1003408486 (7:72805317 A>G), RS1003525608 (7:72752383 T>C), RS1003808607 (7:72752676 A>G), RS1003857949 (7:72756965 C>A,G), RS1004442123 (7:72751200 G>A), RS1005401654 (7:72763993 A>T), RS1005586305 (7:72757906 C>T), RS1005761993 (7:72805267 C>A)

Disease associations

OMIM: gene `` | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

8 associations (top):

StudyTraitp-value
GCST000758_32Triglycerides1.000000e-09
GCST002216_8Triglycerides3.000000e-06
GCST004237_20Triglyceride levels2.000000e-08
GCST008151_111Waist circumference3.000000e-06
GCST008160_63Waist circumference3.000000e-06
GCST009363_14Triglyceride levels x short total sleep time interaction (2df test)1.000000e-56
GCST009364_13Triglyceride levels x long total sleep time interaction (2df test)2.000000e-57
GCST009364_14Triglyceride levels x long total sleep time interaction (2df test)8.000000e-11

EFO canonical traits (1, from GWAS)

EFO IDTrait name
EFO:0004530triglyceride measurement

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

9 total (human), top 9 by PubMed support.

ChemicalActions (top 5)PubMed papers
sodium arseniteincreases expression1
abrineincreases expression1
licochalcone Bincreases expression1
Sunitinibdecreases expression1
Benzo(a)pyreneincreases methylation1
Urethaneincreases expression1
Aflatoxin B1increases methylation1
Okadaic Acidincreases expression1
Acrylamideincreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.